cbdc uk, Overview

18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.South Korean President Yin Xiyue: The opposition party does not recognize the president.A special police camp in Grozny, the capital of the Chechen Republic of Russia, was attacked by drones. Russian military media said that a special police camp in Grozny, the capital of the Chechen Republic, was attacked by Ukrainian drones in the early hours of the 12 th. Up to now, the Ukrainian side has not responded.

Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.

Han Dongxun, leader of South Korea's ruling party: Yin Xiyue has no intention of stepping down early. On December 12, local time, Han Dongxun, leader of South Korea's ruling party, said that President Yin Xiyue confirmed that he had no intention of stepping down early. Han Dongxun said that people involved in the martial law incident, including the president, should be severely punished, and Yin Xiyue should immediately remove the right to operate state affairs, including the commander-in-chief of the army. In addition, Han Dongxun said that he would vote in favor of the impeachment case, and members of the ruling party should vote on the impeachment case according to their conscience.After the shooting of the medical insurance giant executives, the executives of big companies such as Goldman Sachs and Bank of America have also been "targeted". The new york police are adjusting relevant posters, and the new york police are investigating posters posted in some areas of Manhattan about American business executives. In addition CEO Brian Thompson, CEO of UNH insurance business who was shot dead last Wednesday (December 4th), related posters also mentioned executives of American Express, Goldman Sachs Group, Bank of America, JPMorgan Chase and other companies, and their heads were all painted with red "X" signs. A spokesman for the new york police said that in addition to posters, American corporate executives are also facing increasing cyber threats.The two-wheel drive robot industry in the policy market is welcoming the expansion period. The reporter was informed that many places have successively issued relevant policies for the development of the robot industry, planned development goals, and refined measures around improving basic innovation capabilities, accelerating the demonstration application of "robot+"innovation, and promoting the accelerated agglomeration of business entities to accelerate the innovation and development of the robot industry. Recently, Hangzhou released the Development Plan of Humanoid Robot Industry in Hangzhou (2024-2029). Chongqing, Nanjing, Sichuan Tianfu New District and other places have also issued relevant policies to promote the development of the robot industry, and based on the current situation and advantages of industrial development in various regions, promote the further development of the robot industry. Gao Chao, deputy general manager of CCID Consulting Advanced Manufacturing Research Center, said that the scale of China's robot industry is expected to grow to about 400 billion yuan during the Tenth Five-Year Plan period. While accelerating the overall development level of the robot industry, building an industrial innovation system and strengthening product application and promotion have also become the focus of multi-party efforts. Policy and market two-wheel drive have further opened up the development space for robot-related enterprises. (Economic Information Daily)